EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC-ND 4.0

Atypical femur fracture in a patient with indolent mastocytosis: A case report

Michael Wodkowski, Mathieu Boily, Suzanne Morin

Journal of Clinical and Translational Endocrinology: Case Reports · 2018

DOI: 10.1016/j.jecr.2017.12.002 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of Clinical and Translational Endocrinology: Case Reports, 2018. Verfasst von Michael Wodkowski und 2 weiteren Autor:innen. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

• Atypical femur fractures associated with prolonged use of bisphosphonate are most often seen in the setting of osteoporosis treatment. • Teriparatide increased bone remodeling over 6 months and did not result in mastocytosis re-activation. • Prolonged use of IV bisphosphonates should raise concerns in patients with hematologic disorders.

Zitieren

APA

Wodkowski, M., Boily, M., & Morin, S. (2018). Atypical femur fracture in a patient with indolent mastocytosis: A case report. Journal of Clinical and Translational Endocrinology: Case Reports. https://doi.org/10.1016/j.jecr.2017.12.002

Vancouver

Wodkowski M, Boily M, Morin S. Atypical femur fracture in a patient with indolent mastocytosis: A case report. Journal of Clinical and Translational Endocrinology: Case Reports. 2018. doi:10.1016/j.jecr.2017.12.002

BibTeX
@article{Wodkowski2018,
  author = {Wodkowski, Michael and Boily, Mathieu and Morin, Suzanne},
  title = {Atypical femur fracture in a patient with indolent mastocytosis: A case report},
  journal = {Journal of Clinical and Translational Endocrinology: Case Reports},
  year = {2018},
  doi = {10.1016/j.jecr.2017.12.002}
}
Kostenlos starten →